February 17, 2026 · Form 4 insider transaction
Morgen Eric bought 12,500 shares of BioAge Labs, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
The option vested or vests as to 1/48th of the total award monthly, with the first tranche vested on February 1, 2026, and each subsequent tranche vesting on the monthly anniversary thereof, subject to the holder's continued service to the Issuer on each vesting date.; Represents an employee stock option directly held by the reporting person's spouse.